Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

News Conference News ACC 2021

Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs

May 18, 2021

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

December 14, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

March 17, 2020

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

November 07, 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

November 07, 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

November 07, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

August 28, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.